PF K/L | TF K/L | |||||||
---|---|---|---|---|---|---|---|---|
Gene | Variant | Cohort | b | SE | p Value | b | SE | p Value |
GDF5 | rs143383 | GOAL | 0.024 | 0.036 | 0.512 | 0.042 | 0.037 | 0.263 |
HCS | 0.103 | 0.055 | 0.064 | 0.077 | 0.058 | 0.180 | ||
Nottingham | −0.007 | 0.044 | 0.876 | 0.060 | 0.030 | 0.049 | ||
Summary | 0.033 | 0.045 | 0.463 | 0.058 | 0.021 | 0.006 | ||
COG5 | rs4730250 | GOAL | −0.006 | 0.054 | 0.908 | 0.001 | 0.056 | 0.988 |
HCS | 0.175 | 0.085 | 0.041 | 0.108 | 0.089 | 0.225 | ||
Nottingham | 0.021 | 0.047 | 0.657 | 0.016 | 0.037 | 0.655 | ||
Summary | 0.030 | 0.065 | 0.649 | 0.020 | 0.550 | 0.971 | ||
MCF2L | rs11842874 | GOAL | 0.068 | 0.075 | 0.368 | 0.199 | 0.078 | 0.011 |
HCS | 0.190 | 0.112 | 0.091 | −0.119 | 0.117 | 0.312 | ||
Nottingham | 0.084 | 0.100 | 0.402 | −0.108 | 0.069 | 0.121 | ||
Summary | 0.099 | 0.050 | 0.048 | −0.005 | 0.048 | 0.920 |
GOAL, Genetics of Osteoarthritis and Lifestyle study; HCS, Hertfordshire Cohort Study; Nottingham, Nottingham Case-Control Study.